Dr. Amy P. Abernethy is Principal Deputy Commissioner of the US FDA, where she oversees the agency’s day-to-day functioning and directs special and high-priority initiatives.  Prior to joining the FDA, Abernethy was chief medical officer, chief scientific officer and senior vice president of oncology for Flatiron Health. Earlier, she was a professor of medicine at Duke University School of Medicine.…

Keep Reading

Dr. Graeme Archer is VP & Head of the Non-clinical and Translational Statistics (NCTS) group in GSK R&D. NCTS ensures integrity in the design, analysis and interpretation of models and experiments developed by GSK’s Research Units – Graeme is particularly focused on ‘translation’ (what do we predict will be observed in man, and how confident in those predictions should we be?) On GSK’s Research governance boards he strives for statistical rigour in portfolio decision-making –…

Keep Reading

Dr. Berlin received his doctorate in biostatistics from the Harvard School of Public Health in 1988. After spending 15 years as a faculty member at the University of Pennsylvania, in the Center for Clinical Epidemiology and Biostatistics, Jesse left Penn to join Janssen Research & Development in Biostatistics. He now serves as Vice President and Global Head of Epidemiology across Johnson & Johnson, responsible for pharmaceuticals, devices and consumer products. He has coauthored over 270…

Keep Reading

Professor Lawrence Carin is the James L. Meriam Distinguished Professor of Electrical and Computer Engineering at Duke, where he also serves as the Vice Provost for Research. He is one of the most prolific authors in the world in the fields of machine learning and artificial intelligence, regularly publishing in the most competitive forums. He has taught at Duke for over 23 years, and has published nearly 400 peer-reviewed papers. He is also the Chief…

Keep Reading

Professor Noémie Elhadad is an Associate Professor of Biomedical Informatics, affiliated with Computer Science at Columbia University. Her research is at the intersection of machine learning, technology, and medicine. She investigates ways to support clinicians, patients, and health researchers in their information workflow by automatically extracting and making accessible information from unstructured, large, often messy data.…

Keep Reading

Dr. Igor Jurisica, PhD, DrSc is a Senior Scientist at Krembil Research Institute, Professor at U Toronto and Visiting Scientist at IBM CAS. He is an Adjunct Professor at Pathology and Molecular Medicine at Queen’s U, an adjunct scientist at the Institute of Neuroimmunology, Slovak Academy of Sciences, and an Honorary Professor at Shanghai Jiao Tong University. Since 2015, he has also served as Chief Scientist at the Creative Destruction Lab, Rotman School of Management.…

Keep Reading

Dr. Faisal M. Khan is the Executive Director of Advanced Analytics and Artificial Intelligence at AstraZeneca. His work focuses on the intersections of data science, biostatistics, bioimaging, personalized medicine, and healthcare delivery. His career has encompassed all aspects of healthcare and biomedical analytics, including diagnostics, devices, clinical trials/therapeutics, and payers/insurance. Dr. Khan has worked or consulted across academia and industry with both startups and Fortune-50 companies. He has over 90 published papers, abstracts, and patents.…

Keep Reading

Dr. Kannan Natarajan is Head of Global Biometrics and Data Management and is part of Global Product Development Leadership Team at Pfizer Inc. The GBDM organization supports the global clinical development strategy and data sciences across all of Pfizer product portfolio. He is also the Chief Statistical Officer of Pfizer, managing statistical functional excellence across all Pfizer business units. Prior to joining Pfizer, Kannan was Senior Vice President and Global Head of Oncology Biometrics and…

Keep Reading

Dr. Amol Navathe is an Assistant Professor of Health Policy and Medicine and a Senior Fellow at the Leonard Davis Institute for Health Economics at the University of Pennsylvania. Dr. Navathe is a practicing physician, health economist, and engineer. He has extensive expertise in policy analysis and design, physician and hospital economic behavior, and application of informatics and predictive analytics to health care data. His work on advanced health data analytics and technology to improve…

Keep Reading

Dr. Adler Perotte is an Assistant Professor in the Department of Biomedical Informatics as well as the co-founder and faculty advisor to the Health Tech Assembly. Dr. Perotte’s primary research areas are Bayesian inference and prediction based on electronic health record data and metabolomics. Prior to joining the department in this capacity, Dr. Perotte was an NLM Postdoctoral Fellow in Biomedical Informatics at Columbia University. Before that, Dr. Perotte worked as a Research Specialist between…

Keep Reading

Patrick Ryan, PhD is Vice President, Observational Health Data Analytics at Janssen Research and Development, where he is leading efforts to develop and apply analysis methods to better understand the real-world effects of medical products. He is an original collaborator in Observational Health Data Sciences and Informatics (OHDSI), a multi-stakeholder, interdisciplinary collaborative to create open-source solutions that bring out the value of observational health data through large-scale analytics. He served as a principal investigator of…

Keep Reading

Ms. Slack has 30+ years of extensive leadership and management experience in both the public and private sectors, developing informatics strategy and implementing business solutions. She currently serves as Director of FDA’s CDER Office of Strategic Programs (OSP). OSP plays a lead role in many of the Center’s and FDA’s strategic initiatives, including decision support, data standards, program analysis, informatics and governance. Since joining CDER in 2003, Ms. Slack has led numerous large, complex initiatives…

Keep Reading

Professor Simon Tavaré is Professor of Statistics and of Biological Sciences and the Herbert and Florence Irving Director of the Irving Institute for Cancer Dynamics at Columbia University.  Prior to joining Columbia, he was Director of the Cancer Research UK Cambridge Institute, Professor of Cancer Research at the Department of Oncology and Professor in the Department of Applied Mathematics and Theoretical Physics at the University of Cambridge. Simon is a fellow of the Academy of…

Keep Reading

John Humphrey Plummer Professor University of Cambridge Professor van der Schaar is John Humphrey Plummer Professor of Machine Learning, Artificial Intelligence, and Medicine at the University of Cambridge and Turing Faculty Fellow at The Alan Turing Institute in London. She was elected IEEE Fellow (2009) and has received numerous awards, including the Oon Prize on Preventative Medicine from the University of Cambridge (2018).  She holds 35 granted USA patents.  In 2019, she was identified by…

Keep Reading

Dr. Li Wang is currently Senior Director and the Head of Statistical Innovation group in AbbVie.  Prior to this senior leadership role, he led Immunology and Solid Tumor statistical design and strategy discussions and multiple innovation projects in AbbVie Development Design Center from 2017 to 2019. He joined AbbVie in 2013 as the lead statistician for RINVOQ RA phase 2 and multiple other compounds in early immunology in RA, OA and GI. Prior to that,…

Keep Reading